Last 12 months
Inside the activity.
6 purchase rows · 47 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 1 |
| Dec 2025 | 1 | 34 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 4 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 11, 2025 Filed Aug 14, 2025 00:00 UTC |
Wagner Heidi LDirector
|
GrantShare Option (right to buy) · Derivative | 76,200 | $0.00 Strike: $8.11 | $0.00 |
DisclosureSEC source: 0000950170-25-108288 · ownership.xml · derivative · entry 2 Wagner Heidi L · CIK 0001655029 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,200 Underlying: Ordinary Shares · 76,200 shares Expires 2030-08-11 F2 · derivative.exercise_date: The reporting person was granted this option pursuant to the 2025 Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2026 annual general meeting or August 11, 2026. Read SEC document |
| August 11, 2025 Filed Aug 14, 2025 00:00 UTC |
Wagner Heidi LDirector
|
GrantOrdinary Shares | 12,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-108288 · ownership.xml · nonDerivative · entry 1 Wagner Heidi L · CIK 0001655029 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,930 F1 · shares: The reporting person was granted this restricted share unit award (RSU) pursuant to the 2025 Non-Employee Director Compensation Policy. The RSU vests as to 100% of the shares on the earlier of the Company's 2026 annual general meeting or August 11, 2026. Read SEC document |
| August 05, 2025 Filed Aug 8, 2025 00:00 UTC |
TAKANASHI KENDirector
|
SaleOrdinary Shares | 4,872 | $8.75 | $42,630.00 |
DisclosureSEC source: 0000950170-25-105353 · ownership.xml · nonDerivative · entry 1 TAKANASHI KEN · CIK 0001657768 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,716,303 F1 · shares: On August 5, 2025, the reporting person sold 4,872 ordinary shares solely to cover taxes associated with the vesting of restricted share units on August 5, 2025. These sales were made pursuant to a 10b5-1 Trading Plan. Read SEC document |
| August 05, 2025 Filed Aug 8, 2025 00:00 UTC |
Tan Aik NaDirector
|
SaleOrdinary Shares | 1,127 | $8.75 | $9,861.25 |
DisclosureSEC source: 0000950170-25-105352 · ownership.xml · nonDerivative · entry 1 Tan Aik Na · CIK 0001821285 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,988 F1 · shares: On August 5, 2025, the reporting person sold 1,127 ordinary shares solely to cover taxes associated with the vesting of restricted share units on August 5, 2025.These sales were made pursuant to a 10b5-1 Trading Plan. Read SEC document |
| June 13, 2025 Filed Jun 13, 2025 20:00 UTC |
Verdine Gregory L.Director
|
SaleOrdinary Shares | 30,000 | $6.95 | $208,500.00 |
DisclosureSEC source: 0000950170-25-086466 · ownership.xml · nonDerivative · entry 1 Verdine Gregory L. · CIK 0001572315 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 282,517 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025. F2 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $6.79 to $7.04 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 20, 2025 Filed Mar 22, 2025 01:00 UTC |
HENRY CHRISTIAN ODirector
|
Exercise / conversionShare Option (right to buy) · Derivative | 10,500 | $0.00 Strike: $9.13 | $0.00 |
DisclosureSEC source: 0000950170-25-043440 · ownership.xml · derivative · entry 3 HENRY CHRISTIAN O · CIK 0001263805 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 10,500 shares Expires 2025-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2024. F3 · derivative.exercise_date: These share options are fully vested and have an expiration date of August 18, 2025. Read SEC document |
| March 20, 2025 Filed Mar 22, 2025 01:00 UTC |
HENRY CHRISTIAN ODirector
|
SaleOrdinary Shares | 10,500 | $9.77 | $102,574.50 |
DisclosureSEC source: 0000950170-25-043440 · ownership.xml · nonDerivative · entry 2 HENRY CHRISTIAN O · CIK 0001263805 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,115 F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2024. F2 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $9.69 to $9.88 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 20, 2025 Filed Mar 22, 2025 01:00 UTC |
HENRY CHRISTIAN ODirector
|
Exercise / conversionOrdinary Shares | 10,500 | $9.13 | $95,865.00 |
DisclosureSEC source: 0000950170-25-043440 · ownership.xml · nonDerivative · entry 1 HENRY CHRISTIAN O · CIK 0001263805 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,615 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2024. Read SEC document |
| March 07, 2025 Filed Mar 8, 2025 02:05 UTC |
BOLNO PAULDirector · President and CEO
|
Exercise / conversionShare Option (right to buy) · Derivative | 48,059 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0000950170-25-035835 · ownership.xml · derivative · entry 4 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 48,059 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The options reported in this Form 4 were set to expire on Monday, March 10, 2025. The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024. F3 · derivative.exercise_date: These share options are fully vested and have an expiration date of Monday, March 10, 2025. Read SEC document |
| March 07, 2025 Filed Mar 8, 2025 02:05 UTC |
BOLNO PAULDirector · President and CEO
|
Exercise / conversionShare Option (right to buy) · Derivative | 120,966 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0000950170-25-035835 · ownership.xml · derivative · entry 3 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 120,966 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The options reported in this Form 4 were set to expire on Monday, March 10, 2025. The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024. F3 · derivative.exercise_date: These share options are fully vested and have an expiration date of Monday, March 10, 2025. Read SEC document |
| March 07, 2025 Filed Mar 8, 2025 02:05 UTC |
BOLNO PAULDirector · President and CEO
|
SaleOrdinary Shares | 169,025 | $9.57 | $1,617,569.25 |
DisclosureSEC source: 0000950170-25-035835 · ownership.xml · nonDerivative · entry 2 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 338,351 F1 · kind: The options reported in this Form 4 were set to expire on Monday, March 10, 2025. The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024. F2 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $9.12 to $10.10 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 07, 2025 Filed Mar 8, 2025 02:05 UTC |
BOLNO PAULDirector · President and CEO
|
Exercise / conversionOrdinary Shares | 169,025 | $2.48 | $419,182.00 |
DisclosureSEC source: 0000950170-25-035835 · ownership.xml · nonDerivative · entry 1 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 507,376 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The options reported in this Form 4 were set to expire on Monday, March 10, 2025. The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024. Read SEC document |
| March 07, 2025 Filed Mar 7, 2025 21:00 UTC |
Verdine Gregory L.Director
|
Exercise / conversionShare Option (right to buy) · Derivative | 133,402 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0000950170-25-035834 · ownership.xml · derivative · entry 4 Verdine Gregory L. · CIK 0001572315 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 133,402 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The share options that were exercised via cash purchase in this reportable transaction were fully vested. Read SEC document |
| March 07, 2025 Filed Mar 7, 2025 21:00 UTC |
Verdine Gregory L.Director
|
Exercise / conversionOrdinary Shares | 133,402 | $2.48 | $330,836.96 |
DisclosureSEC source: 0000950170-25-035834 · ownership.xml · nonDerivative · entry 2 Verdine Gregory L. · CIK 0001572315 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 312,517 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:00 UTC |
Verdine Gregory L.Director
|
Exercise / conversionShare Option (right to buy) · Derivative | 133,000 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0000950170-25-035834 · ownership.xml · derivative · entry 3 Verdine Gregory L. · CIK 0001572315 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,402 Underlying: Ordinary Shares · 133,000 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The share options that were exercised via cash purchase in this reportable transaction were fully vested. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:00 UTC |
Verdine Gregory L.Director
|
Exercise / conversionOrdinary Shares | 133,000 | $2.48 | $329,840.00 |
DisclosureSEC source: 0000950170-25-035834 · ownership.xml · nonDerivative · entry 1 Verdine Gregory L. · CIK 0001572315 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,155 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 17:14 UTC |
Vargeese ChandraSee Remarks
|
Exercise / conversionShare Option (right to buy) · Derivative | 75,332 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0000950170-25-033838 · ownership.xml · derivative · entry 3 Vargeese Chandra · CIK 0001657675 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 75,332 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The share options that were exercised via cash purchase in this reportable transaction were fully vested. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 17:14 UTC |
Vargeese ChandraSee Remarks
|
Exercise / conversionShare Option (right to buy) · Derivative | 16,422 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0000950170-25-033838 · ownership.xml · derivative · entry 2 Vargeese Chandra · CIK 0001657675 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 16,422 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The share options that were exercised via cash purchase in this reportable transaction were fully vested. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 17:14 UTC |
Vargeese ChandraSee Remarks
|
Exercise / conversionOrdinary Shares | 91,754 | $2.48 | $227,549.92 |
DisclosureSEC source: 0000950170-25-033838 · ownership.xml · nonDerivative · entry 1 Vargeese Chandra · CIK 0001657675 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 362,687 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 20:00 UTC |
Vargeese ChandraSee Remarks
|
GrantShare Option (right to buy) · Derivative | 224,000 | $0.00 Strike: $11.74 | $0.00 |
DisclosureSEC source: 0000950170-25-015679 · ownership.xml · derivative · entry 2 Vargeese Chandra · CIK 0001657675 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,000 Underlying: Ordinary Shares · 224,000 shares Expires 2035-02-04 F2 · derivative.exercise_date: The option vests as to 25% of the shares on February 8, 2026, and vests as to an additional 6.25% of the shares quarterly thereafter until February 8, 2029. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 20:00 UTC |
Vargeese ChandraSee Remarks
|
GrantOrdinary Shares | 37,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-015679 · ownership.xml · nonDerivative · entry 1 Vargeese Chandra · CIK 0001657675 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,933 F1 · shares: Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 8, 2026 through February 8, 2029. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 20:00 UTC |
Francis ChrisSee Remarks
|
GrantShare Option (right to buy) · Derivative | 151,000 | $0.00 Strike: $11.74 | $0.00 |
DisclosureSEC source: 0000950170-25-015680 · ownership.xml · derivative · entry 2 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,000 Underlying: Ordinary Shares · 151,000 shares Expires 2035-02-04 F2 · derivative.exercise_date: The option vests as to 25% of the shares on February 8, 2026, and vests as to an additional 6.25% of the shares quarterly thereafter until February 8, 2029. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 20:00 UTC |
Francis ChrisSee Remarks
|
GrantOrdinary Shares | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-015680 · ownership.xml · nonDerivative · entry 1 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 F1 · shares: Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 8, 2026 through February 8, 2029. Read SEC document |
| February 04, 2025 Filed Feb 7, 2025 01:00 UTC |
BOLNO PAULDirector · President and CEO
|
GrantShare Option (right to buy) · Derivative | 1,000,000 | $0.00 Strike: $11.74 | $0.00 |
DisclosureSEC source: 0000950170-25-015681 · ownership.xml · derivative · entry 2 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Ordinary Shares · 1,000,000 shares Expires 2035-02-04 F2 · derivative.exercise_date: The option vests as to 25% of the shares on February 8, 2026, and vests as to an additional 6.25% of the shares quarterly thereafter until February 8, 2029. Read SEC document |
| February 04, 2025 Filed Feb 7, 2025 01:00 UTC |
BOLNO PAULDirector · President and CEO
|
GrantOrdinary Shares | 121,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-015681 · ownership.xml · nonDerivative · entry 1 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338,351 F1 · shares: Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 8, 2026 through February 8, 2029. Read SEC document |
| February 04, 2025 Filed Feb 7, 2025 01:00 UTC |
Moran KyleChief Financial Officer
|
GrantShare Option (right to buy) · Derivative | 252,000 | $0.00 Strike: $11.74 | $0.00 |
DisclosureSEC source: 0000950170-25-015682 · ownership.xml · derivative · entry 2 Moran Kyle · CIK 0001657765 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,000 Underlying: Ordinary Shares · 252,000 shares Expires 2035-02-04 F3 · derivative.exercise_date: The option vests as to 25% of the shares on February 8, 2026, and vests as to an additional 6.25% of the shares quarterly thereafter until February 8, 2029. Read SEC document |
| February 04, 2025 Filed Feb 7, 2025 01:00 UTC |
Moran KyleChief Financial Officer
|
GrantOrdinary Shares | 42,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-015682 · ownership.xml · nonDerivative · entry 1 Moran Kyle · CIK 0001657765 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,218 F1 · shares: Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 8, 2026 through February 8, 2029. F2 · balance_after: Includes 2,441 ordinary shares acquired on January 14, 2025, under the issuer's 2019 Employee Share Purchase Plan. Read SEC document |
| January 23, 2025 Filed Jan 24, 2025 17:30 UTC |
Vargeese ChandraSee Remarks
|
Exercise / conversionShare Option (right to buy) · Derivative | 46,000 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0000950170-25-008909 · ownership.xml · derivative · entry 2 Vargeese Chandra · CIK 0001657675 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,422 Underlying: Ordinary Shares · 46,000 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The share options that were exercised via cash purchase in this reportable transaction were fully vested. Read SEC document |
| January 23, 2025 Filed Jan 24, 2025 17:30 UTC |
Vargeese ChandraSee Remarks
|
Exercise / conversionOrdinary Shares | 46,000 | $2.48 | $114,080.00 |
DisclosureSEC source: 0000950170-25-008909 · ownership.xml · nonDerivative · entry 1 Vargeese Chandra · CIK 0001657675 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,872 ordinary shares acquired on January 14, 2025, under the issuer's 2019 Employee Share Purchase Plan. Read SEC document |
| November 25, 2024 Filed Nov 28, 2024 02:00 UTC |
BOLNO PAULDirector · President and CEO
|
Exercise / conversionShare Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0000950170-24-131691 · ownership.xml · derivative · entry 3 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,778 Underlying: Ordinary Shares · 50,000 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024. F2 · derivative.exercise_date: These share options are fully vested. Read SEC document |
| November 25, 2024 Filed Nov 28, 2024 02:00 UTC |
BOLNO PAULDirector · President and CEO
|
SaleOrdinary Shares | 50,000 | $15.00 | $750,000.00 |
DisclosureSEC source: 0000950170-24-131691 · ownership.xml · nonDerivative · entry 2 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 217,351 F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024. Read SEC document |
| November 25, 2024 Filed Nov 28, 2024 02:00 UTC |
BOLNO PAULDirector · President and CEO
|
Exercise / conversionOrdinary Shares | 50,000 | $2.48 | $124,000.00 |
DisclosureSEC source: 0000950170-24-131691 · ownership.xml · nonDerivative · entry 1 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 267,351 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024. Read SEC document |
| November 15, 2024 Filed Nov 16, 2024 02:00 UTC |
BOLNO PAULDirector · President and CEO
|
SaleOrdinary Shares | 51,234 | $14.32 | $733,670.88 |
DisclosureSEC source: 0000950170-24-127740 · ownership.xml · nonDerivative · entry 1 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 217,351 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2024. F2 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $14.11 to $15.18 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 20:00 UTC |
Francis ChrisSee Remarks
|
Exercise / conversionShare Option (right to buy) · Derivative | 36,000 | $0.00 Strike: $8.17 | $0.00 |
DisclosureSEC source: 0000950170-24-126622 · ownership.xml · derivative · entry 3 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 36,000 shares Expires 2030-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The share options that were exercised in this reportable transaction were fully vested. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 20:00 UTC |
Francis ChrisSee Remarks
|
SaleOrdinary Shares | 36,000 | $16.00 | $576,000.00 |
DisclosureSEC source: 0000950170-24-126622 · ownership.xml · nonDerivative · entry 2 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 20:00 UTC |
Francis ChrisSee Remarks
|
Exercise / conversionOrdinary Shares | 36,000 | $8.17 | $294,120.00 |
DisclosureSEC source: 0000950170-24-126622 · ownership.xml · nonDerivative · entry 1 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023. Read SEC document |
| October 16, 2024 Filed Oct 18, 2024 20:00 UTC |
Francis ChrisSee Remarks
|
Exercise / conversionShare Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $2.83 | $0.00 |
DisclosureSEC source: 0000950170-24-115726 · ownership.xml · derivative · entry 10 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,500 Underlying: Ordinary Shares · 22,500 shares Expires 2032-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The share options that were exercised in this reportable transaction were fully vested. Read SEC document |
| October 16, 2024 Filed Oct 18, 2024 20:00 UTC |
Francis ChrisSee Remarks
|
Exercise / conversionShare Option (right to buy) · Derivative | 65,625 | $0.00 Strike: $3.14 | $0.00 |
DisclosureSEC source: 0000950170-24-115726 · ownership.xml · derivative · entry 9 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 84,375 Underlying: Ordinary Shares · 65,625 shares Expires 2032-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The share option represented the right to purchase a total of 150,000 ordinary shares, 25% of which became exercisable on January 1, 2023, and the remaining shares vest as to an additional 6.25% quarterly thereafter until January 1, 2026. Read SEC document |
| October 16, 2024 Filed Oct 18, 2024 20:00 UTC |
Francis ChrisSee Remarks
|
Exercise / conversionShare Option (right to buy) · Derivative | 40,997 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0000950170-24-115726 · ownership.xml · derivative · entry 8 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 40,997 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The share options that were exercised in this reportable transaction were fully vested. Read SEC document |
| October 16, 2024 Filed Oct 18, 2024 20:00 UTC |
Francis ChrisSee Remarks
|
SaleOrdinary Shares | 22,500 | $13.50 | $303,750.00 |
DisclosureSEC source: 0000950170-24-115726 · ownership.xml · nonDerivative · entry 7 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023. Read SEC document |
| October 16, 2024 Filed Oct 18, 2024 20:00 UTC |
Francis ChrisSee Remarks
|
Exercise / conversionOrdinary Shares | 22,500 | $2.83 | $63,675.00 |
DisclosureSEC source: 0000950170-24-115726 · ownership.xml · nonDerivative · entry 6 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023. Read SEC document |
| October 16, 2024 Filed Oct 18, 2024 20:00 UTC |
Francis ChrisSee Remarks
|
SaleOrdinary Shares | 65,625 | $13.75 | $902,343.75 |
DisclosureSEC source: 0000950170-24-115726 · ownership.xml · nonDerivative · entry 5 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023. Read SEC document |
| October 16, 2024 Filed Oct 18, 2024 20:00 UTC |
Francis ChrisSee Remarks
|
Exercise / conversionOrdinary Shares | 65,625 | $3.14 | $206,062.50 |
DisclosureSEC source: 0000950170-24-115726 · ownership.xml · nonDerivative · entry 4 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023. Read SEC document |
| October 16, 2024 Filed Oct 18, 2024 20:00 UTC |
Francis ChrisSee Remarks
|
SaleOrdinary Shares | 40,997 | $13.00 | $532,961.00 |
DisclosureSEC source: 0000950170-24-115726 · ownership.xml · nonDerivative · entry 3 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023. Read SEC document |
| October 16, 2024 Filed Oct 18, 2024 20:00 UTC |
Francis ChrisSee Remarks
|
Exercise / conversionOrdinary Shares | 40,997 | $2.48 | $101,672.56 |
DisclosureSEC source: 0000950170-24-115726 · ownership.xml · nonDerivative · entry 2 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,997 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023. Read SEC document |
| October 16, 2024 Filed Oct 18, 2024 20:00 UTC |
Francis ChrisSee Remarks
|
SaleOrdinary Shares | 79,714 | $14.00 | $1,115,996.00 |
DisclosureSEC source: 0000950170-24-115726 · ownership.xml · nonDerivative · entry 1 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023. Read SEC document |
| October 16, 2024 Filed Oct 19, 2024 00:00 UTC |
BOLNO PAULDirector · President and CEO
|
SaleOrdinary Shares | 90,474 | $15.00 | $1,357,110.00 |
DisclosureSEC source: 0000950170-24-115725 · ownership.xml · nonDerivative · entry 1 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 268,585 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2024. Read SEC document |
| October 11, 2024 Filed Oct 12, 2024 00:00 UTC |
Moran KyleChief Financial Officer
|
Exercise / conversionShare Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0000950170-24-114422 · ownership.xml · derivative · entry 2 Moran Kyle · CIK 0001657765 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 25,000 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The share options that were exercised via cash purchase in this reportable transaction were fully vested. Read SEC document |
| October 11, 2024 Filed Oct 12, 2024 00:00 UTC |
Moran KyleChief Financial Officer
|
Exercise / conversionOrdinary Shares | 25,000 | $2.48 | $62,000.00 |
DisclosureSEC source: 0000950170-24-114422 · ownership.xml · nonDerivative · entry 1 Moran Kyle · CIK 0001657765 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 27, 2024 Filed Oct 1, 2024 21:54 UTC |
GSK plc10% owner
|
PurchaseOrdinary Shares | 2,791,930 | $8.00 | $22,335,440.00 |
DisclosureSEC source: 0001999371-24-012789 · wve-form4_092724.xml · nonDerivative · entry 1 GSK plc · CIK 0001131399 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Corporation Disclosed balance after: 16,775,691 F1 · ownership.nature: The shares reported herein are held of record by Glaxo Group Limited, a wholly-owned subsidiary of GSK plc (the "Reporting Person"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.